This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amersham International Plc. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Nicholas Ian Workman
Introduction
Nicholas Ian Workman is a notable inventor based in Aylesbury, GB. He has made significant contributions to the field of biotechnology, particularly through his innovative patent related to drug screening technologies. His work exemplifies the intersection of scientific research and practical application.
Latest Patents
Nicholas Ian Workman holds a patent for a "Reverse two-hybrid system employing post-translation signal modulation." This invention pertains to modified two-hybrid systems, specifically a reverse two-hybrid system that utilizes a reporter gene encoding a modifying agent, such as an enzyme. The system produces a detectable signal when there is an inhibition of binding between the two hybrid proteins, making it particularly useful for drug screening. He has 1 patent to his name.
Career Highlights
Workman is associated with Amersham International Plc, where he has contributed to various projects that leverage his expertise in biotechnology. His role at the company has allowed him to work on cutting-edge technologies that have the potential to impact drug development and screening processes.
Collaborations
Throughout his career, Nicholas has collaborated with esteemed colleagues, including Susan Jane Dale and Douglas Hurd. These partnerships have fostered an environment of innovation and have led to advancements in their respective fields.
Conclusion
Nicholas Ian Workman is a distinguished inventor whose work in biotechnology has paved the way for new methodologies in drug screening. His contributions are a testament to the importance of innovation in scientific research and its applications in the medical field.